단백질 특성 분석 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품 및 서비스별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Protein Characterization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Application, By End-Use, By Region and Competition, 2020-2030F
상품코드:1807174
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 단백질 특성 분석 시장 규모는 2024년에 154억 5,000만 달러로 평가되었고, 2030년에는 340억 7,000만 달러에 이를 것으로 예측되며, CAGR은 14.06%를 나타낼 전망입니다.
세계의 단백질 특성 분석 시장은 단백질체학가 중시되게 되어, 세포 기능이나 질병 메커니즘의 해명에 있어서 그 역할이 높아지고 있기 때문에 견조한 확대를 볼 수 있습니다. 중요한 바이오마커와 치료 표적인 단백질은 신약, 진단, 맞춤형 의료의 핵심입니다. 이러한 이유로 생명공학 및 제약 회사는 첨단 단백질 분석 기술에 대한 투자를 촉진하고 있습니다. 질량 분석, 크로마토그래피, 전기영동과 같은 도구는 단백질 구조, 번역 후 변형, 상호작용 연구에 널리 사용됩니다. 정밀의료 및 생물 제제에 대한 수요 증가는 정확한 단백질 프로파일링의 필요성을 더욱 가속화하고 있습니다. 생명 과학 연구에 대한 정부 보조금 증가와 학술 기관과 기업 간의 공동 연구의 활성화는 시장 확대를 지원합니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
154억 5,000만 달러
시장 규모 : 2030년
340억 7,000만 달러
CAGR : 2025-2030년
14.06%
급성장 부문
신약 개발 및 연구
최대 시장
북미
시장을 형성하는 동향은 단백질 분석에서 인공지능과 머신러닝의 통합을 포함하여 보다 신속한 데이터 처리 및 예측 모델링을 가능하게 합니다. 자동화 및 고처리량 스크리닝 기술은 분석 시간을 단축하고 재현성을 향상시켜 대규모 용도의 효율성을 향상시킵니다. 단백질체학와 유전체학 및 대사체학를 결합한 멀티오믹스 접근법의 출현은 생물학적 인사이트의 깊이를 높이고 종합적인 프로파일링을 촉진합니다. 소형화된 랩 칩 플랫폼은 특히 임상 진단에서 포인트 오브 케어 용도의 견인 역할을 하고 있습니다. 업계 각사는 원활한 데이터 통합, 해석, 시각화를 가능하게 하는 사용하기 쉬운 소프트웨어 툴의 개발에도 주력하고 있어 연구자의 발견을 가속화하고 있습니다.
주요 시장 성장 촉진요인
생물제제 및 바이오시밀러 수요 증가
주요 시장 과제
장비 및 분석 서비스의 높은 비용
주요 시장 동향
단일클론항체 및 생물제제 개발 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 단백질 특성 분석 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
제품 및 서비스별(소모품, 기기, 서비스)
용도별(신약 개발, 임상 진단, 기타)
용도별(제약 및 바이오테크놀러지 기업, 학술 연구 기관, 계약 연구 기관, 기타)
기업별(2024년)
지역별
시장 맵
제6장 북미의 단백질 특성 분석 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 단백질 특성 분석 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 단백질 특성 분석 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 단백질 특성 분석 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 단백질 특성 분석 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
합병과 인수
제품 출시
최근 동향
제13장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bruker Corporation
Thermo Fisher Scientific Inc.
Danaher Corporation
Eurofins Scientific
Merck KGAA
Promega Corporation
Qiagen NV
Sartorius AG
제15장 전략적 제안
제16장 기업 소개와 면책사항
KTH
영문 목차
영문목차
Global Protein Characterization Market was valued at USD 15.45 Billion in 2024 and is expected to reach USD 34.07 Billion by 2030 with a CAGR of 14.06%. The Global Protein Characterization Market is witnessing robust expansion due to the growing emphasis on proteomics and its role in understanding cellular functions and disease mechanisms. Proteins, being key biomarkers and therapeutic targets, are central to drug discovery, diagnostics, and personalized medicine. This has prompted biotechnology and pharmaceutical companies to invest in advanced protein analysis technologies. Tools such as mass spectrometry, chromatography, and electrophoresis are widely used to study protein structure, post-translational modifications, and interactions. Increasing demand for precision medicine and biologics has further accelerated the need for accurate protein profiling. Rising government funding for life sciences research and an uptick in collaborations between academic institutions and industry players are supporting the market's expansion.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 15.45 Billion
Market Size 2030
USD 34.07 Billion
CAGR 2025-2030
14.06%
Fastest Growing Segment
Drug Discovery & Development
Largest Market
North America
Trends shaping the market include the integration of artificial intelligence and machine learning in protein analysis, enabling faster data processing and predictive modeling. Automation and high-throughput screening technologies are reducing analysis time and improving reproducibility, making protein characterization more efficient for large-scale applications. The emergence of multi-omics approaches, combining proteomics with genomics and metabolomics, is enhancing the depth of biological insights and encouraging comprehensive profiling. Miniaturized and lab-on-chip platforms are gaining traction for point-of-care applications, especially in clinical diagnostics. Industry players are also focusing on developing user-friendly software tools that allow seamless data integration, interpretation, and visualization, helping researchers accelerate discoveries.
Key Market Drivers
Rising Demand for Biologics and Biosimilars
The increasing demand for biologics and biosimilars is a significant driver for the Global Protein Characterization Market. Biologics, including monoclonal antibodies, therapeutic proteins, and vaccines, are revolutionizing the treatment of various diseases, particularly in oncology, autoimmune disorders, and genetic diseases. As these therapies continue to grow in importance, the need for precise and comprehensive protein characterization and identification becomes crucial. Protein characterization techniques allow for the analysis of protein structures, functions, and interactions, which is vital for ensuring the safety, efficacy, and quality of biologic drugs.
In 2023, the U.S. Food and Drug Administration (FDA) approved 55 new drugs, of which 17 were biologics, accounting for 30.9% of all drug approvals. Notably, 12 of these biologics were monoclonal antibodies, marking a significant milestone in biologic drug development. The Center for Biologics Evaluation and Research (CBER) added 23 new biologics license application approvals in 2023, highlighting the growing focus on biologic therapies.
Similarly, the European Medicines Agency (EMA) recommended 77 medicines for marketing authorization in 2023, with 39 having a new active substance. This indicates a strong emphasis on innovative therapies, including biologics, in the European market.
The increasing focus on biosimilars, which are similar to original biologic drugs but at a lower cost, further fuels the demand for protein characterization. As the patents of several blockbuster biologics expire, pharmaceutical companies are investing heavily in the development of biosimilars to tap into this growing market. Ensuring the structural and functional similarity of biosimilars to their reference biologics is critical, and this requires advanced protein characterization methods such as mass spectrometry, chromatography, and peptide mapping.
Regulatory agencies worldwide, including the FDA and EMA, have established rigorous guidelines to assess the quality and safety of biologics and biosimilars, which in turn drives the need for precise protein identification techniques. As biologic therapies gain popularity and the biosimilars market expands, the demand for protein characterization and identification solutions will continue to rise, accelerating market growth and innovation in this sector.
Key Market Challenges
High Cost of Instruments and Analytical Services
The high cost of instruments and analytical services remains a significant challenge for the Global Protein Characterization Market. Cutting-edge protein characterization tools such as mass spectrometers, chromatography systems, and protein analyzers are critical for accurate and reliable results. These advanced instruments often come with hefty price tags, making them unaffordable for smaller research institutions, universities, and laboratories, particularly in emerging markets. The expense associated with these technologies can create a barrier to entry for organizations with limited financial resources, thereby hindering widespread adoption of advanced protein characterization methods.
Beyond the high initial purchase cost, maintaining and operating these instruments requires specialized training, skilled personnel, and regular servicing, all of which add to the ongoing expenses. The need for highly trained technicians and scientists to operate these advanced technologies further drives up operational costs. Additionally, the reliance on specialized reagents and consumables for protein analysis can contribute to the overall expense. For many research entities, these financial constraints may limit the frequency of protein characterization studies and the scope of their research projects.
Key Market Trends
Rise in Monoclonal Antibody and Biologics Development
The rise in monoclonal antibody (mAb) and biologics development is significantly driving the Global Protein Characterization Market. With the growing emphasis on biologic therapies, including monoclonal antibodies, protein characterization and identification have become essential to ensuring the safety, efficacy, and consistency of these therapies. As biologics are increasingly utilized for treating chronic diseases, cancers, and autoimmune conditions, accurate protein analysis is vital to understanding their molecular structures, functionality, and therapeutic potential. This trend is particularly pronounced with the growing use of mAbs, which are highly complex molecules that require precise characterization for both drug development and regulatory approval.
The growing complexity of biologics has led to increased demand for advanced proteomics tools, such as mass spectrometry and chromatography, to analyze proteins and their interactions. This demand is expected to rise as the pharmaceutical industry focuses on personalized medicine, where the detailed profiling of proteins in the context of individual patients is crucial. Accurate protein identification is pivotal in the development of next-generation biologics, as even slight structural variations can impact the therapeutic outcome.
Key Market Players
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bruker Corporation
Thermo Fisher Scientific Inc.
Danaher Corporation
Eurofins Scientific
Merck KGAA
Promega Corporation
Qiagen N.V.
Sartorius AG
Report Scope:
In this report, the Global Protein Characterization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Protein Characterization Market, By Product & Services:
Consumables
Instruments
Services
Protein Characterization Market, By Application:
Drug Discovery & Development
Clinical Diagnosis
Others
Protein Characterization Market, By End-Use:
Pharmaceuticals & Biotechnology Companies
Academic Research Institutes
Contract Research Organizations
Others
Protein Characterization Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Protein Characterization Market.
Available Customizations:
Global Protein Characterization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Protein Characterization Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Services (Consumables, Instruments, Services)
5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Protein Characterization Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product & Services
6.2.2. By Application
6.2.3. By End-Use
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Protein Characterization Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product & Services
6.3.1.2.2. By Application
6.3.1.2.3. By End-Use
6.3.2. Mexico Protein Characterization Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product & Services
6.3.2.2.2. By Application
6.3.2.2.3. By End-Use
6.3.3. Canada Protein Characterization Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product & Services
6.3.3.2.2. By Application
6.3.3.2.3. By End-Use
7. Europe Protein Characterization Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product & Services
7.2.2. By Application
7.2.3. By End-Use
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Protein Characterization Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product & Services
7.3.1.2.2. By Application
7.3.1.2.3. By End-Use
7.3.2. Germany Protein Characterization Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product & Services
7.3.2.2.2. By Application
7.3.2.2.3. By End-Use
7.3.3. United Kingdom Protein Characterization Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product & Services
7.3.3.2.2. By Application
7.3.3.2.3. By End-Use
7.3.4. Italy Protein Characterization Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product & Services
7.3.4.2.2. By Application
7.3.4.2.3. By End-Use
7.3.5. Spain Protein Characterization Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product & Services
7.3.5.2.2. By Application
7.3.5.2.3. By End-Use
8. Asia-Pacific Protein Characterization Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product & Services
8.2.2. By Application
8.2.3. By End-Use
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Protein Characterization Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product & Services
8.3.1.2.2. By Application
8.3.1.2.3. By End-Use
8.3.2. India Protein Characterization Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product & Services
8.3.2.2.2. By Application
8.3.2.2.3. By End-Use
8.3.3. South Korea Protein Characterization Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product & Services
8.3.3.2.2. By Application
8.3.3.2.3. By End-Use
8.3.4. Japan Protein Characterization Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product & Services
8.3.4.2.2. By Application
8.3.4.2.3. By End-Use
8.3.5. Australia Protein Characterization Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product & Services
8.3.5.2.2. By Application
8.3.5.2.3. By End-Use
9. South America Protein Characterization Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product & Services
9.2.2. By Application
9.2.3. By End-Use
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Protein Characterization Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product & Services
9.3.1.2.2. By Application
9.3.1.2.3. By End-Use
9.3.2. Argentina Protein Characterization Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product & Services
9.3.2.2.2. By Application
9.3.2.2.3. By End-Use
9.3.3. Colombia Protein Characterization Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product & Services
9.3.3.2.2. By Application
9.3.3.2.3. By End-Use
10. Middle East and Africa Protein Characterization Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product & Services
10.2.2. By Application
10.2.3. By End-Use
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Protein Characterization Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product & Services
10.3.1.2.2. By Application
10.3.1.2.3. By End-Use
10.3.2. Saudi Arabia Protein Characterization Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product & Services
10.3.2.2.2. By Application
10.3.2.2.3. By End-Use
10.3.3. UAE Protein Characterization Market Outlook
